Leukoaraiosis on magnetic resonance imaging is related to long-term poor functional outcome after thrombolysis in acute ischemic stroke

Journal of Korean Neurosurgical Society

Volumn 50, Issue 2, 2011, Pages 75-80

  Choi, Jae Hyung ^a   Bae, Hyo Jin ^a   Cha, Jae Kwan ^a  

^a Dong A University   (South Korea)

Author keywords

Acute ischemic stroke; Intracerebral hemorrhage; Leukoaraiosis; Thrombolysis

Indexed keywords

BLOOD CLOTTING INHIBITOR; GLUCOSE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN ATHEROSCLEROSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DIABETES MELLITUS; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FUNCTIONAL STATUS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; RANKIN SCALE; RECANALIZATION; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 80053283949     PISSN: 20053711     EISSN: 15987876     Source Type: Journal    
DOI: 10.3340/jkns.2011.50.2.75     Document Type: Article

References (30)

1. Ariës MJ, Uyttenboogaart M, Vroomen PC, De Keyser J, Luijckx GJ: tPA treatment for acute ischaemic stroke in patients with leukoaraiosis. Eur J Neurol 17: 866-870, 2010
2. Arsava EM, Rahman R, Rosand J, Lu J, Smith EE, Rost NS, et al.: Severity of leukoaraiosis correlates with clinical outcome after ischemic stroke. Neurology 72: 1403-1410, 2009
3. de Leeuw FE, de Groot JC, Achten E, Oudkerk M, Ramos LM, Heijboer R, et al.: Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 70: 9-14, 2001
4. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M: PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 29: 4-11, 1998
5. del Zoppo GJ, von Kummer R, Hamann GF: Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke. J Neurol Neurosurg Psychiatry 65: 1-9, 1998
6. Demchuk AM, Khan F, Hill MD, Barber PA, Silver B, Patel S, et al.: Importance of leukoaraiosis on CT for tissue plasminogen activator decision making: evaluation of the NINDS rt-PA Stroke Study. Cerebrovasc Dis 26: 120-125, 2008
7. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA: MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 149: 351-356, 1987
8. Görner A, Lemmens R, Schrooten M, Thijs V: is leukoaraiosis on CT an accurate surrogate marker for the presence of microbleeds in acute stroke patients? J Neurol 254: 284-289, 2007
9. Gorter JW: Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups. Neurology 53: 1319-1327, 1999
10. Hachinski VC, Potter P, Merskey H: Leuko-araiosis. Arch Neurol 44: 21-23, 1987
11. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al.: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 352: 1245-1251, 1998
12. Iwamoto T, Kubo H, Takasaki M: Platelet activation in the cerebral circulation in different subtypes of ischemic stroke and Binswanger's disease. Stroke 26: 52-56, 1995
13. Jørgensen HS, Nakayama H, Raaschou HO, Olsen TS: Leukoaraiosis in stroke patients. The Copenhagen Stroke Study. Stroke 26: 588-592, 1995
14. Koennecke HC: Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications. Neurology 66: 165-171, 2006
15. Lee SJ, Kim JS, Lee KS, An JY, Kim W, Kim YI, et al.: The leukoaraiosis is more prevalent in the large artery atherosclerosis stroke subtype among Korean patients with ischemic stroke. BMC Neurol 8: 31, 2008
16. Longstreth WT Jr, Bernick C, Manolio TA, Bryan N, Jungreis CA, Price TR: Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol 55: 1217-1225, 1998
17. Neumann-Haefelin T, Hoelig S, Berkefeld J, Fiehler J, Gass A, Humpich M, et al.: Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke 37: 2463-2466, 2006
18. Nordahl CW, Ranganath C, Yonelinas AP, Decarli C, Fletcher E, Jagust WJ: White matter changes compromise prefrontal cortex function in healthy elderly individuals. J Cogn Neurosci 18: 418-429, 2006
19. O'Sullivan M, Lythgoe DJ, Pereira AC, Summers PE, Jarosz JM, Williams SC, et al.: Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology 59: 321-326, 2002
20. Pantoni L, Garcia JH: Pathogenesis of leukoaraiosis: a review. Stroke 28: 652-659, 1997
21. Singer OC, Humpich MC, Fiehler J, Albers GW, Lansberg MG, Kastrup A, et al.: Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging. Ann Neurol 63: 52-60, 2008
22. Smith EE: Leukoaraiosis and stroke. Stroke 41: S139-S143, 2010
23. Smith EE, Rosand J, Knudsen KA, Hylek EM, Greenberg SM: Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke. Neurology 59: 193-197, 2002
24. Tanne D, Kasner SE, Demchuk AM, Koren-Morag N, Hanson S, Grond M, et al.: Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation 105: 1679-1685, 2002
25. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333: 1581-1587, 1995
26. Thein SS, Hamidon BB, Teh HS, Raymond AA: Leukoaraiosis as a predictor for mortality and morbidity after an acute ischaemic stroke. Singapore Med J 48: 396-399, 2007
27. van Swieten JC, Kappelle LJ, Algra A, van Latum JC, Koudstaal PJ, van Gijn J: Hypodensity of the cerebral white matter in patients with transient ischemic attack or minor stroke: influence on the rate of subsequent stroke. Dutch TIA Trial Study Group. Ann Neurol 32: 177-183, 1992
28. Weimar C, König IR, Kraywinkel K, Ziegler A, Diener HC: Age and National Institutes of Health Stroke Scale Score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models. Stroke 35: 158-162, 2004
29. Whitman GT, Tang Y, Lin A, Baloh RW: A prospective study of cerebral white matter abnormalities in older people with gait dysfunction. Neurology 57: 990-994, 2001
30. Yamanouchi H, Sugiura S, Tomonaga M: Decrease in nerve fibres in cerebral white matter in progressive subcortical vascular encephalopathy of Binswanger type. An electron microscopic study. J Neurol 236: 382-387, 1989